These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 19879105

  • 1. The Rho kinase inhibitor fasudil inhibits the migratory behaviour of 95-D lung carcinoma cells.
    Yang X, Liu Y, Zong Z, Tian D.
    Biomed Pharmacother; 2010 Jan; 64(1):58-62. PubMed ID: 19879105
    [Abstract] [Full Text] [Related]

  • 2. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
    Yang X, Di J, Zhang Y, Zhang S, Lu J, Liu J, Shi W.
    Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
    [Abstract] [Full Text] [Related]

  • 3. Effect of fasudil on growth, adhesion, invasion, and migration of 95D lung carcinoma cells in vitro.
    Yang X, Zhang Y, Wang S, Shi W.
    Can J Physiol Pharmacol; 2010 Sep; 88(9):874-9. PubMed ID: 20921973
    [Abstract] [Full Text] [Related]

  • 4. Intraradial administration of fasudil inhibits augmented Rho kinase activity to effectively dilate the spastic radial artery during coronary artery bypass grafting surgery.
    Takagi T, Okamoto Y, Tomita S, Sato A, Yamaguchi S, Takuwa Y, Watanabe G.
    J Thorac Cardiovasc Surg; 2011 Aug; 142(2):e59-65. PubMed ID: 21397262
    [Abstract] [Full Text] [Related]

  • 5. Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549.
    Zhu F, Zhang Z, Wu G, Li Z, Zhang R, Ren J, Nong L.
    Med Oncol; 2011 Jun; 28(2):565-71. PubMed ID: 20300976
    [Abstract] [Full Text] [Related]

  • 6. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L, Li G, Li R, Liu Q, He Q, Zhang J.
    Cancer Biol Ther; 2010 Jun 01; 9(11):875-84. PubMed ID: 20364104
    [Abstract] [Full Text] [Related]

  • 7. Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells.
    Zhang X, Wu N.
    Drug Des Devel Ther; 2018 Jun 01; 12():373-381. PubMed ID: 29503530
    [Abstract] [Full Text] [Related]

  • 8. [Suppression of hepatocellular carcinoma invasion and metastasis by Rho-kinase inhibitor Fasudil through inhibition of BTBD7-ROCK2 signaling pathway].
    Hu K, Wang Z, Tao Y.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Dec 01; 39(12):1221-7. PubMed ID: 25544168
    [Abstract] [Full Text] [Related]

  • 9. Fasudil inhibits LPS-induced migration of retinal microglial cells via regulating p38-MAPK signaling pathway.
    Xu F, Xu Y, Zhu L, Rao P, Wen J, Sang Y, Shang F, Liu Y.
    Mol Vis; 2016 Dec 01; 22():836-46. PubMed ID: 27441000
    [Abstract] [Full Text] [Related]

  • 10. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
    Ying H, Biroc SL, Li WW, Alicke B, Xuan JA, Pagila R, Ohashi Y, Okada T, Kamata Y, Dinter H.
    Mol Cancer Ther; 2006 Sep 01; 5(9):2158-64. PubMed ID: 16985048
    [Abstract] [Full Text] [Related]

  • 11. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
    Gao H, Hou F, Dong R, Wang Z, Zhao C, Tang W, Wu Y.
    Cardiovasc Ther; 2016 Oct 01; 34(5):352-9. PubMed ID: 27333569
    [Abstract] [Full Text] [Related]

  • 12. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
    Liu H, Chen X, Han Y, Li C, Chen P, Su S, Zhang Y, Pan Z.
    Biomed Pharmacother; 2014 Apr 01; 68(3):267-75. PubMed ID: 24406296
    [Abstract] [Full Text] [Related]

  • 13. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts.
    Zhou H, Zhang KX, Li YJ, Guo BY, Wang M, Wang M.
    Clin Exp Pharmacol Physiol; 2011 Jun 01; 38(6):387-94. PubMed ID: 21457293
    [Abstract] [Full Text] [Related]

  • 14. Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
    Xia Y, Cai XY, Fan JQ, Zhang LL, Ren JH, Chen J, Li ZY, Zhang RG, Zhu F, Wu G.
    Mol Cancer Ther; 2015 Jul 01; 14(7):1582-90. PubMed ID: 25934709
    [Abstract] [Full Text] [Related]

  • 15. ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells.
    Guerra FS, Oliveira RG, Fraga CAM, Mermelstein CDS, Fernandes PD.
    Sci Rep; 2017 Oct 20; 7(1):13723. PubMed ID: 29057980
    [Abstract] [Full Text] [Related]

  • 16. Fasudil protects cultured N1E-115 cells against lysophosphatidic acid-induced neurite retraction through inhibition of Rho-kinase.
    Satoh S, Kawasaki K, Hitomi A, Ikegaki I, Asano T.
    Brain Res Bull; 2011 Feb 01; 84(2):174-7. PubMed ID: 21126559
    [Abstract] [Full Text] [Related]

  • 17. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY, Dun JN, Miao QF, Zhang YJ.
    Pharmacology; 2009 Feb 01; 83(2):67-79. PubMed ID: 19052484
    [Abstract] [Full Text] [Related]

  • 18. Fasudil inhibits lung carcinoma-conditioned endothelial cell viability and migration.
    Zhang Z, Ren JH, Li ZY, Nong L, Wu G.
    Oncol Rep; 2012 May 01; 27(5):1561-6. PubMed ID: 22344855
    [Abstract] [Full Text] [Related]

  • 19. Fasudil inhibits prostate cancer-induced angiogenesis in vitro.
    Chen W, Mao K, Hua-Huy T, Bei Y, Liu Z, Dinh-Xuan AT.
    Oncol Rep; 2014 Dec 01; 32(6):2795-802. PubMed ID: 25333508
    [Abstract] [Full Text] [Related]

  • 20. Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice.
    Wu DJ, Xu JZ, Wu YJ, Jean-Charles L, Xiao B, Gao PJ, Zhu DL.
    Atherosclerosis; 2009 Nov 01; 207(1):68-73. PubMed ID: 19473657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.